You are here

Biblio

Author Title Type [ Year(Asc)]
Filters: Keyword is tau Proteins  [Clear All Filters]
2021
Walker JM, Fudym Y, Farrell K, Iida MA, Bieniek KF, Seshadri S, White CL, Crary JF, Richardson TE.  2021.  Asymmetry of Hippocampal Tau Pathology in Primary Age-Related Tauopathy and Alzheimer Disease.. J Neuropathol Exp Neurol. 80(5):436-445.
Kim JPyo, Kim B-H, Bice PJ, Seo SWon, Bennett DA, Saykin AJ, Nho K.  2021.  BMI1 is associated with CS8F amyloid-β and rates of cognitive decline in Alzheimer's disease.. Alzheimers Res Ther. 13(1):164.
Patrick E, Olah M, Taga M, Klein H-U, Xu J, White CC, Felsky D, Agrawal S, Gaiteri C, Chibnik LB et al..  2021.  A cortical immune network map identifies distinct microglial transcriptional programs associated with β-amyloid and Tau pathologies.. Transl Psychiatry. 11(1):50.
Xu H, O'Reilly M, Gibbons GS, Changolkar L, McBride JD, Riddle DM, Zhang B, Stieber A, Nirschl J, Kim S-J et al..  2021.  In vitro amplification of pathogenic tau conserves disease-specific bioactive characteristics.. Acta Neuropathol. 141(2):193-215.
Brickman AM, Manly JJ, Honig LS, Sanchez D, Reyes-Dumeyer D, Lantigua RA, Lao PJ, Stern Y, Vonsattel JPaul, Teich AF et al..  2021.  Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community study.. Alzheimers Dement. 17(8):1353-1364.
Wang S, Lindroth H, Chan C, Greene R, Serrano-Andrews P, Khan S, Rios G, Jabbari S, Lim J, Saykin AJ et al..  2021.  A Systematic Review of Delirium Biomarkers and Their Alignment with the NIA-AA Research Framework.. J Am Geriatr Soc. 69(1):255-263.
2020
Friedberg JS, Aytan N, Cherry JD, Xia W, Standring OJ, Alvarez VE, Nicks R, Svirsky S, Meng G, Jun G et al..  2020.  Associations between brain inflammatory profiles and human neuropathology are altered based on apolipoprotein E ε4 genotype.. Sci Rep. 10(1):2924.
Kling MA, Goodenowe DB, Senanayake V, MahmoudianDehkordi S, Arnold M, Massaro TJ, Baillie R, Han X, Leung Y-Y, Saykin AJ et al..  2020.  Circulating ethanolamine plasmalogen indices in Alzheimer's disease: Relation to diagnosis, cognition, and CSF tau.. Alzheimers Dement. 16(9):1234-1247.
Jo T, Nho K, Risacher SL, Saykin AJ.  2020.  Deep learning detection of informative features in tau PET for Alzheimer's disease classification.. BMC Bioinformatics. 21(Suppl 21):496.
Ibañez L, Bahena JA, Yang C, Dube U, Farias FHG, Budde JP, Bergmann K, Brenner-Webster C, Morris JC, Perrin RJ et al..  2020.  Functional genomic analyses uncover APOE-mediated regulation of brain and cerebrospinal fluid beta-amyloid levels in Parkinson disease.. Acta Neuropathol Commun. 8(1):196.
Ewers M, Biechele G, Suárez-Calvet M, Sacher C, Blume T, Morenas-Rodriguez E, Deming Y, Piccio L, Cruchaga C, Kleinberger G et al..  2020.  Higher CSF sTREM2 and microglia activation are associated with slower rates of beta-amyloid accumulation.. EMBO Mol Med. 12(9):e12308.
Weitzman SA, Narasimhan S, He Z, Changolkar L, McBride JD, Zhang B, Schellenberg GD, Trojanowski JQ, M Y Lee V.  2020.  Insoluble Tau From Human FTDP-17 Cases Exhibit Unique Transmission Properties In Vivo.. J Neuropathol Exp Neurol. 79(9):941-949.
Strickland SL, Reddy JS, Allen M, N'songo A, Burgess JD, Corda MM, Ballard T, Wang X, Carrasquillo MM, Biernacka JM et al..  2020.  MAPT haplotype-stratified GWAS reveals differential association for AD risk variants.. Alzheimers Dement. 16(7):983-1002.
He Z, McBride JD, Xu H, Changolkar L, Kim S-J, Zhang B, Narasimhan S, Gibbons GS, Guo JL, Kozak M et al..  2020.  Transmission of tauopathy strains is independent of their isoform composition.. Nat Commun. 11(1):7.

Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer